Document is current
Any future updates will be listed below
-
Authors
Hannah, Labinsky https://orcid.org/0000-0001-5762-9182
von Sophie, Rohr https://orcid.org/0009-0005-1509-266X
Gabriella, Raimondo Maria https://orcid.org/0000-0003-2020-6711
Daniela, Bohr https://orcid.org/0000-0002-3894-2496
Harriet, Morf https://orcid.org/0000-0001-6688-2155
Britta, Horstmann https://orcid.org/0009-0001-3735-0288
Felix, Seese https://orcid.org/0009-0005-8897-4698
Fabian, Proft https://orcid.org/0000-0003-4306-033X
Felix, Muehlensiepen https://orcid.org/0000-0001-8571-7286
Katharina, Boy https://orcid.org/0009-0009-9616-6278
Sebastian, Kuhn https://orcid.org/0000-0002-8031-2973
Marc, Schmalzing https://orcid.org/0000-0002-3289-2299
Nicolas, Vuillerme https://orcid.org/0000-0003-3773-393X
Georg, Schett https://orcid.org/0000-0001-8740-9615
Andreas, Ramming https://orcid.org/0000-0002-7003-501X
Johannes, Knitza https://orcid.org/0000-0001-9695-0657
-
Funding
Funding for this research was provided by:
Novartis Pharma GmbH, Nürnberg, Germany
Deutsche Forschungsgemeinschaft
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 19 April 2023
Accepted: 31 May 2023
First Online: 14 June 2023
Declarations
:
: The study was approved on 3<sup>rd</sup> of November 2021 by the ethics committee of the University hospital Erlangen-Nürnberg (Reg no. 21-357-B). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual respondents included in the study.
